search
Back to results

Predicting Pediatric Pulmonary Vein Stenosis Outcomes Using Data Acquired During a Cardiac Catheterization

Primary Purpose

Pulmonary Vein Stenosis

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standardized catheterization assessment
Sponsored by
Boston Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Pulmonary Vein Stenosis

Eligibility Criteria

undefined - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pediatric patients undergoing cardiac catheterization for the indication of known or suspicion for intraluminal pulmonary vein stenosis.

Exclusion Criteria:

  • Hemodynamically unstable patients as determined by the patient care team.

Sites / Locations

  • Boston Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Standardized catheterization assessment

Arm Description

Assessment of pulmonary veins including angiography, intravascular ultrasound, pressure assessment and compliance testing.

Outcomes

Primary Outcome Measures

Pulmonary vein status
Severity of pulmonary vein stenosis (score 0 to 3); Score 0: Unobstructed vein (best outcome), Score 1: Proximal vein disease, Score 2: Distal vein disease, Score 3: Vein atresia (worst outcome).

Secondary Outcome Measures

Patient status
Transplant free survival

Full Information

First Posted
January 4, 2021
Last Updated
September 11, 2023
Sponsor
Boston Children's Hospital
Collaborators
Children's Hospital of Philadelphia
search

1. Study Identification

Unique Protocol Identification Number
NCT04696289
Brief Title
Predicting Pediatric Pulmonary Vein Stenosis Outcomes Using Data Acquired During a Cardiac Catheterization
Official Title
Predicting Pediatric Intraluminal Pulmonary Vein Stenosis Outcomes Using a Comprehensive Standardized Catheterization Assessment
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 26, 2021 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
February 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital
Collaborators
Children's Hospital of Philadelphia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, single center study which applies a standardized, comprehensive catheterization assessment to patients with a known or suspected diagnosis of pulmonary vein stenosis (PVS) who are undergoing a cardiac catheterization at Boston Children's Hospital. As part of the assessment, each pulmonary vein will undergo angiography (pictures using moving x-rays and contrast dye), intravascular ultrasound (IVUS; pictures of the vein wall using a catheter inside the vein), pressure assessment and compliance testing. The status of each pulmonary vein will then be assessed 12 months after the catheterization (i.e. no disease, severe disease, etc.). Using statistics, the investigators will determine which patient and vein characteristics (obtained at the of catheterization) can predict whether or not a pulmonary vein will have disease. The investigators hypothesize that this comprehensive, standardized, invasive assessment of pediatric intraluminal PVS can predict vein outcome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Vein Stenosis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standardized catheterization assessment
Arm Type
Experimental
Arm Description
Assessment of pulmonary veins including angiography, intravascular ultrasound, pressure assessment and compliance testing.
Intervention Type
Diagnostic Test
Intervention Name(s)
Standardized catheterization assessment
Intervention Description
There are four components to the pulmonary vein assessment. Angiography: pulmonary artery wedge injection and/or selective pulmonary vein injection. Intravascular ultrasound: manual pullback of IVUS catheter from lobar segment to left atrium. Pressure assessment: pulmonary vein pressure (mmHg) measured before and after (if applicable) intervention. Compliance testing: the compliance of the vein will be measured using a compliant conventional balloon.
Primary Outcome Measure Information:
Title
Pulmonary vein status
Description
Severity of pulmonary vein stenosis (score 0 to 3); Score 0: Unobstructed vein (best outcome), Score 1: Proximal vein disease, Score 2: Distal vein disease, Score 3: Vein atresia (worst outcome).
Time Frame
12 months +/- 6 weeks or prior to study exit due to death or lung transplant
Secondary Outcome Measure Information:
Title
Patient status
Description
Transplant free survival
Time Frame
12 months

10. Eligibility

Sex
All
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pediatric patients undergoing cardiac catheterization for the indication of known or suspicion for intraluminal pulmonary vein stenosis. Exclusion Criteria: Hemodynamically unstable patients as determined by the patient care team.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jesse Esch, MD
Phone
6173558228
Email
jesse.esch@cardio.chboston.org
First Name & Middle Initial & Last Name or Official Title & Degree
Mirjam Keochakian, BS
Phone
6179196090
Email
Mirjam.Keochakian@childrens.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jesse Esch, MD
Organizational Affiliation
Boston Children's Hospital/Harvard Medical School
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boston Children's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jesse Esch, MD
Phone
617-355-8228
Email
jesse.esch@cardio.chboston.org
First Name & Middle Initial & Last Name & Degree
Mirjam Keochakian, BS
Phone
617-919-6090
Email
Mirjam.Keochakian@childrens.harvard.edu

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
11009286
Citation
Sadr IM, Tan PE, Kieran MW, Jenkins KJ. Mechanism of pulmonary vein stenosis in infants with normally connected veins. Am J Cardiol. 2000 Sep 1;86(5):577-9, A10. doi: 10.1016/s0002-9149(00)01022-5.
Results Reference
background
PubMed Identifier
28622179
Citation
Kovach AE, Magcalas PM, Ireland C, McEnany K, Oliveira AM, Kieran MW, Baird CW, Jenkins K, Vargas SO. Paucicellular Fibrointimal Proliferation Characterizes Pediatric Pulmonary Vein Stenosis: Clinicopathologic Analysis of 213 Samples From 97 Patients. Am J Surg Pathol. 2017 Sep;41(9):1198-1204. doi: 10.1097/PAS.0000000000000892.
Results Reference
background
PubMed Identifier
29576325
Citation
Callahan R, Kieran MW, Baird CW, Colan SD, Gauvreau K, Ireland CM, Marshall AC, Sena LM, Vargas SO, Jenkins KJ. Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis. J Pediatr. 2018 Jul;198:29-35.e5. doi: 10.1016/j.jpeds.2018.01.029. Epub 2018 Mar 23.
Results Reference
background
PubMed Identifier
32936535
Citation
Callahan R, Jenkins KJ, Gauthier Z, Gauvreau K, Porras D. Preliminary findings on the use of intravascular ultrasound in the assessment of pediatric pulmonary vein stenosis. Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E362-E370. doi: 10.1002/ccd.29264. Epub 2020 Sep 16.
Results Reference
background

Learn more about this trial

Predicting Pediatric Pulmonary Vein Stenosis Outcomes Using Data Acquired During a Cardiac Catheterization

We'll reach out to this number within 24 hrs